Original Research

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

Régnier SA, Malcolm W, Haig J, Xue W

ClinicoEconomics and Outcomes Research 2015, 7:235-247

Published Date: 6 May 2015